Back to Journals » Nature and Science of Sleep » Volume 16
Causal Associations Between Sleep Traits and Low Grip Strength: A Bidirectional Mendelian Randomization Study
Authors Tai Y, Wang H , Dai Y, Yu L
Received 24 June 2024
Accepted for publication 13 September 2024
Published 22 October 2024 Volume 2024:16 Pages 1699—1711
DOI https://doi.org/10.2147/NSS.S480491
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Ahmed BaHammam
Yihong Tai,1,* Haonan Wang,1,* Yinghong Dai,2,* Liang Yu1,3
1Department of Exercise Physiology, School of Sport Science, Beijing Sport University, Beijing, 100084, People’s Republic of China; 2Xiangya School of Medicine, Central South University, Changsha, 410008, People’s Republic of China; 3Engineering Research Center of Strength and Conditioning Training Key Core Technology Integrated System and Equipment of Ministry of Education, Beijing Sport University, Beijing, 100084, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Liang Yu, Engineering Research Center of Strength and Conditioning Training Key Core Technology Integrated System and Equipment of Ministry of Education, Beijing Sport University, Beijing, 100084, People’s Republic of China, Tel/Fax +86 1062967640, Email [email protected]
Background: Sleep disorders and low grip strength often co-occur clinically and are geriatric symptoms that cause significant socioeconomic burden. Previous observational studies have found an association between sleep behaviors and grip strength, but the causal relationship remains unclear.
Purpose: With the Mendelian randomization (MR) approach, the study aimed to determine the causal association between sleep traits (sleep duration, insomnia, daytime napping, sleep-wake disorders, chronotype) and low grip strength.
Methods: The study used genetic variants from the genome-wide association study (GWAS) archived in UK Biobank and FinnGen. We assessed the potential causal relationship between sleep behaviors and grip strength using inverse variance weighting (IVW), weighted median (WM), and MR-Egger. Additionally, we performed sensitivity analyses using Cochran’s Q test, MR Egger Intercept test, funnel plots, and leave-one-out method.
Results: We found that sleep duration is causally negatively associated with low grip strength (OR = 0.618, 95% CI = 0.424– 0.900, P = 0.012). Sleep-wake disorders have a positive association with low grip strength (OR = 1.018, 95% CI = 1.002– 1.034, P = 0.029). Reversely, high low grip strength risk was causally associated with increased daytime napping (OR = 1.018, 95% CI = 1.004– 1.032, P = 0.011).
Conclusion: The study revealed causal associations between sleep duration, sleep-wake disorders, and low grip strength. Understanding their relationship helps in early clinical intervention to improve the life quality of the elderly.
Keywords: sleep, low grip strength, Mendelian randomization
Introduction
Low grip strength is a common debilitating dysfunction, and not only predicts a decline in muscle mass and function, but is also associated with falls and reduced mobility.1 Meta-analyses have demonstrated that low grip strength elevates the risk of a variety of diseases, including cardiovascular diseases,2 type 2 diabetes,3 obesity,4 and chronic obstructive pulmonary disease.5 In addition, multiple previous studies support the association of weak grip strength with increased all-cause mortality in the general and old population.6–8
Sleep quality is a key evaluator of sleep, and sleep quality is recognized as one of the key factors affecting grip strength.9 Previous studies have demonstrated that poor sleep quality was associated with decreased muscle mass and decreased grip strength.10,11 This may be due to the fact that poor sleep quality affects the metabolism of hormones, among which insulin-like growth factor 1 (IGF-1) is a central factor to muscle protein synthesis.12 Sleep patterns are also significant for sleep health,13 yet sleep patterns change with age independent of other factors such as comorbidities and medications.14 Several prospective cohorts have also examined the strong correlation between circadian rhythm disruption and skeletal muscle damage in humans.15,16 Epidemiological studies have shown that poor sleep quality is prevalent in the old, with about half or more complaining about their sleep problems.17,18 Therefore, it is essential to explore the effects of sleep on grip strength levels in the elderly.
Most of the current studies on sleep and grip strength are observational and are susceptible to confounding factors, making it difficult to confirm a causal relationship. In addition, most of these studies utilized cross-sectional designs, so it is difficult to infer causality and the direction of causality. To strengthen causal inference, we apply a novel genetically informed method. Mendelian randomization (MR) is an approach that uses genetic variants as instruments to estimate the causal effects of the exposure on outcome.19 Since genotypes are randomly assigned from parents to offspring, they are not subject to reverse causality and confounding factors.20
As mentioned earlier, there may be a correlation between sleep traits and low grip strength, but evidence of causality is lacking. This study aimed to investigate the causal relationship between several sleep traits and low grip strength and shed light on the causal directions, providing a theoretical basis for clinical improvement of life quality in the elderly.
Materials and Methods
Study Design
We used a bidirectional, two-sample MR design to examine the relationship between sleep traits and low grip strength. Analyses were conducted using sleep traits: (i) as the exposure to assess whether sleep traits have a causal effect on low grip strength and sleep traits, and (ii) as the outcome to assess whether low grip strength has a causal effect on sleep traits. Summary data for all exposure and outcome variables were obtained from large-scale genome-wide association studies (GWAS) of individuals of European ancestry. We assessed the role of five different sleep traits on low grip strength. These included sleep duration, insomnia, sleep-wake disorders, daytime napping, and chronotype. In addition, Figure 1 summarizes the core MR assumptions for the study design.21
This study is reported as per the Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization (STROBE-MR) guideline (Supplementary Table S1).22 All original studies included in the GWAS datasets were ethically approved, and informed consent was obtained from all participants.
Data Sources
Summary data for five sleep traits, including sleep duration (n = 460,099),23,24 insomnia (n = 307,751),25 sleep-wake disorders (n = 305,359),25 daytime napping (n = 452,633),26 and chronotype (n = 449,734),27 were obtained from GWAS studies in the UK Biobank and FinnGen (R7 release). The UK Biobank is a large-scale biomedical database containing genetic and health information from approximately half a million United Kingdom participants aged between 40 and 69. The FinnGen research project collected biological samples from 500,000 participants with a median age of 63 years in Finland over six years. The details of sleep traits data sources used in this study are in Table 1.
![]() |
Table 1 Details of GWAS Datasets About Sleep Traits |
For low grip strength, the summary data were obtained from a recent GWAS meta-analysis on muscle weakness.28 The study included 48,596 old adults (aged from 60 to 90 years) of European ancestry with the European Working Group on Sarcopenia in Older People definition (grip strength < 30 kg Male; < 20 kg Female), adjusted for sex, age, and technical covariates.
Genetic Instruments Selection
As genetic instruments, single nucleotide polymorphisms (SNPs) associated with each trait at genome-wide significance (P < 5×10−8) were extracted. For phenotypes with insufficient SNPs reaching the threshold, we selected instruments with a relaxed threshold (P < 5×10−5). Then, SNPs were clumped to obtain independent loci using a threshold of linkage disequilibrium (LD) r2 < 0.001 and a distance of 10,000 kb. When SNPs for the exposure were unavailable in the outcome phenotype data, we replaced them with proxy SNPs in high-linkage disequilibrium (r2 > 0.800) using the LDlink (https://ldlink.nih.gov/?tab=ldproxy). Furthermore, we removed SNPs strongly associated with outcome (P < 5×10−8). Then, we considered several factors to be potential confounders of the association between sleep traits and grip strength: body mass index (BMI), fracture, poor appetite, bone mineral density, waist circumference, dementia, insulin resistance, strenuous physical activity, oxidative protein damage, age at menarche, depression, fall status, and cardiorespiratory. Furthermore, we removed SNPs with potential reverse causal effects by the Steiger filtering (Steiger P > 0.05).29 Finally, to quantify the strength of instrumental variables (IVs), we calculated F-statistics. F-statistics > 10 suggests that the combined SNPs in our MR model are a sufficiently strong instrument to explain phenotypic variants.30 The list of instruments for each phenotype is shown in Supplementary Table S2.
Statistical Analyses
This study used the random-effect inverse-variance weighted (IVW) method to estimate overall causal effects. It is considered the most predictive method, assuming no directional pleiotropy.31 Then, we conducted the weighted-Median method, which gives a credible estimate of effect when up to half of the weight is derived from valid IVs.32 In addition, the MR-Egger method provided a causal estimate using the slope of the weighted linear regression against horizontal pleiotropy.33
We conducted several sensitivity analyses to further estimate the MR results’ robustness. Cochran’s Q statistic evaluated Heterogeneity across IVs.34 We performed the MR-Egger intercept test to assess horizontal pleiotropy.35 The stability of these genetic variants is measured by funnel plots and leave-one-out method.33 In addition, Mendelian Randomization Pleiotropy Residual Sum and Outlier (MR-PRESSO) was used to identify potential pleiotropic outliers and provided estimates after excluding these outlier SNPs.35 Moreover, we looked up each instrument SNP and their proxies (r2> 0.80) in the PhenoScanner database to assess associations with potential confounding (P < 1 × 10−5). We assessed the effects of manually removing these SNPs from the MR analysis to rule out possible pleiotropic effects. Finally, because some exposure data were derived from UK Biobank and outcome data were derived from several GWAS meta-analysis results, there is some inevitable partial sample overlap. We used MRlap method to assess the potential resulting bias.36 If the difference between the raw and adjusted IVW effects was insignificant (P > 0.05), the raw IVW estimates could be trusted. Conversely, if we found the difference significant (P < 0.05), we prioritize the adjusted IVW estimates as it is not affected by sample overlap.
All statistical analyses were conducted in the R software (version 4.2.2) using the TwoSampleMR, MR-PRESSO, and MRlap packages.37 Effect estimates are reported in odds ratio (OR) with 95% confidence intervals (CI), and P < 0.05 was considered statistically significant.
Results
Causal Effects of Sleep Traits and Low Grip Strength
The F-statistics for five sleep traits were above of 10 (12.09–32.67), indicating that the selected IVs has enough power to avoid potential weak instruments bias effectively.38,39 The summary results of all the analyses for sleep traits on low grip strength are shown in Figure 2 and Table 2.
![]() |
Table 2 MR Analyses with Heterogeneity, Sensitivity, and Pleiotropy Evaluation for Causal Effects of Sleep Traits on LGS |
We obtained 36 significant independent SNPs as IVs for sleep duration, excluding 24 confounder-associated variants, 1 incompatible SNP, and 10 palindromic SNPs. The IVW result showed that sleep duration was negatively associated with low grip strength (OR = 0.62, 95% CI = 0.42–0.90, P = 0.012 < 0.05) (Figure 3). The weighted median and MR-Egger results showed the same direction as those of IVW (OR < 1.00). Moreover, the MR-Egger intercept test showed no significant horizontal pleiotropy (P > 0.05), and MR-PRESSO did not identify any pleiotropic outliers. Funnel plot and leave-one-out analysis showed no single SNP biased effect estimates (Supplementary Figures S1 and S2). MRlap analysis showed no significant difference between the raw and adjusted IVW estimates (P > 0.05).
For sleep-wake disorders, we got 18 IVs using relaxed P-value thresholds (P < 5×10−5) after removing 1 palindromic SNP. Notably, for the large-scale GWAS study on sleep-wake disorders (n = 305,359) that we used, relaxing the P-value thresholds may have increased the true positive discovery at the cost of adding few additional false positive results.40 We found sleep-wake disorders was significantly associated with low grip strength (IVW: OR = 1.02, 95% CI = 1.00–1.03, P = 0.020 < 0.05) (Figure 4). Consistent with the IVW result, the Weighted median and MR-Egger showed a positive causal direction (OR > 1.00). The Cochran’s Q and MR-Egger intercept tests showed no obvious heterogeneity and horizontal pleiotropy (P > 0.05). In addition, no outlier IVs were identified in the MR-PRESSO analysis. Funnel plots and leave-one-out analyses showed single SNP did not bias the result (Supplementary Figures S3 and S4). MRlap analysis showed no significant differences between the raw and adjusted IVW P-values for sleep-wake disorders (P > 0.05).
Besides, we did not find a significant causal relationship between the genetically predicted insomnia, daytime napping, and chronotype with low grip strength (IVW P > 0.05). In the sensitivity analyses, the MR-PRESSO results for chronotype showed rs76277841 played a contradictory role with other SNPs. However, we still could not find a causal relationship between chronotype and low grip strength after removing it (OR = 0.95, 95% CI = 0.65–1.40, P = 0.802). MRlap analyses for these three sleep traits similarly showed no significant difference between the raw and adjusted (for sample overlap) IVW P-values (P > 0.05). The visualization of the sensitivity analyses is shown in Supplementary Figures S5–S13.
Causal Effects of Low Grip Strength on Sleep Traits
In reverse analyses, we found a significant positive association low grip strength and between daytime napping (IVW: OR = 1.02, 95% CI = 1.00–1.03, P = 0.011 < 0.05) (Figure 5). Notably, the IVs used for daytime napping had removed the specific SNP (rs3771501), influencing the effect estimates found by the leave-one-out analysis. Similar to the IVW result, the Weighted median and MR-Egger also showed a positive causal direction (OR > 1.00). Cochran’s Q and MR-Egger intercept tests showed no significant heterogeneity or horizontal pleiotropy (P > 0.05). MR-PRESSO did not identify any outliers. Furthermore, funnel plots and leave-one-out analysis verified the robustness of the findings (Supplementary Figures S14 and S15). MRlap analysis showed a significant difference between the raw and adjusted IVW P-values (P = 0.007 < 0.05). However, the MRlap corrected results were consistent with the primary MR analysis result (corrected IVW: OR = 1.08, 95% CI = 0.94–1.23, P = 0.044 < 0.05), which confirms that the IVW method is robust. The results of reverse MR are summarized in Figure 6 and Table 3.
![]() |
Table 3 MR Analyses with Heterogeneity, Sensitivity, and Pleiotropy Evaluation for Causal Effects of LGS on Sleep Traits |
However, we failed to find a potential causal relationship between genetically predicted low grip strength and sleep duration, insomnia, sleep-wake disorders, and chronotype (IVW P > 0.05). Moreover, MRlap analyses revealed a significant difference between raw and corrected IVW P-values for low hand grip strength to Insomnia (P = 0.049 < 0.05) and Sleep-wake disorders analyses (P = 0.004 < 0.05). Similarly, the corrected results of low grip strength to Insomnia and Sleep-wake disorders were consistent with the primary MR results (corrected IVW: P = 0.856 and 0.428 > 0.05). For the MRlap result for low grip strength to chronotype, no significant difference was observed between the raw and adjusted IVW P-values (P > 0.05). All sensitivity analyses showed that the results are robust (Supplementary Figure S16–S27).
Discussion
Using bi-directional two-sample MR with genetic instruments selected from large-scale GWAS, we found evidence supporting a potential causal relationship between sleep traits and reduced risk for low grip strength. The study is the first bi-directional MR study to investigate causality between sleep traits and low grip strength. Low grip strength is an early marker of age-related functional decline and a strong predictor of morbidity and mortality in various diseases.41 Previous studies have revealed the association of grip strength with physical functioning and independence in community-dwelling older adults.42 Therefore, preventing low grip strength is important for improving population health, especially among older adults. Based on the results, we revealed a significant negative causal effect of sleep duration on low grip strength, indicating that longer sleep duration is associated with a lower occurrence of low grip strength. In addition, the result proposes a causality association between low grip strength risk and sleep-wake disorders. Reversely, low grip strength achieved a significant causal effect with daytime napping. However, there was no evidence of a causal association between insomnia, chronotype and low grip strength.
Sleep duration is a key trait in sleep quality.43 Aging disrupts circadian rhythms and is a risk factor for decreased sleep duration;44 it also increases the risk of falls, representing the risk of decreased muscle strength.45 As two corollaries of aging, however, researches on the correlation between sleep duration and grip strength in older adults are controversial.9,46 An observational study has shown no evidence of a correlation between lower sleep duration and sarcopenia.47 However, a systematic review including 21 cross-sectional, 3 prospective studies, and 92,363 subjects indicated the robust association between sleep duration and muscle health.48 Typically, previous studies concluded that the shorter the sleep duration, the lower the skeletal muscle mass index and the higher risk of low grip strength.49 The old adults with mid-sleep (6–7 h) had significantly higher hand grip strength than those with short-sleep (≤ 5 h).50 However, recent studies have suggested that either too long or too short sleep duration may lead to sarcopenia and manifest as low grip strength.51,52 Our findings support an appropriate increase in sleep duration, which may be a protective factor for low grip strength, improving quality of life in older adults. Skeletal muscle is composed of 80% protein.53 When sleep is reduced, the metabolic state of protein is reduced anabolism and/or increased catabolism, which partially explains the decrease in muscle mass when sleep is reduced, and also fits with our results.54 IGF-1 is a key protein for muscle growth and directly upregulates skeletal muscle protein synthesis through activation of PI3k/Akt/mTOR.53 Sleep deprivation leads to a decrease in circulating IGF-1, which in turn affects muscle synthesis.55 Besides the involvement of protein metabolism in muscle synthesis, glucose also has an effect on muscle metabolism. Muscle is the largest organ in the human body and consumes a large amount of glucose every day to maintain its energy supply and glucose homeostasis.56,57 Reduced sleep induces insulin resistance, leading to reduced glucose uptake by muscles and reduced muscle synthesis.58,59 In addition, skeletal muscle possesses a sleep-regulated cell-autonomous molecular clock, and maintaining adequate sleep is essential for muscle mass, growth, and metabolic regulation.60–62
Daytime napping appeared to be a beneficial strategy to enhance the recovery process and counteract some of the adverse effects of sleep deprivation on physical and cognitive performance.63 In observational studies, a higher risk of functional limitations (low grip strength and propensity to fall) was associated with increased daytime napping, but this could not be fully explained by adjusting for demographics or health status.64 Using MR analyses, we found the causality and its direction: low grip strength may be a causative factor for daytime napping. Previous studies corroborated the plausibility of the results: low hand grip strength was an important symptom of frailty and tended to be highly associated with daytime napping.65,66 However, the clinical significance of this result should be interpreted cautiously as the OR was very close to 1 (OR = 1.018). Increased physical activity increases muscle mass and reduces the incidence of low grip strength.67 This may help to reduce the incidence of daytime napping, and thus reduce the risk of multiple diseases associated with excessive daytime sleepiness.68
Almost all sleep-related phenotypes can be categorized as sleep-wake disorders (or sleep disorders) according to American Psychiatric Association definition.69 The causal associations of sleep duration, sleep-wake disorders to low grip strength, and low grip strength to daytime napping may be related to circadian rhythm mechanisms in skeletal muscle.70 Causes of sleep disorders include delayed circadian rhythm with aging, lower physical function and/or activity, and decreased social interactions.71,72 Studies have shown that long-term sleep disorders alter the body’s normal biological rhythms, and indirectly impair skeletal muscle structure, function, and metabolism.16 In addition to the aforementioned effects of protein metabolism on muscle production, previous studies have shown that patients with sleep disorders are predisposed to develop metabolic syndrome.16 And the pathological processes that characterize metabolic syndrome, insulin resistance and persistent inflammation, weaken muscle mass.73 Moreover, the rhythmicity of skeletal muscle itself is thought to affect sleep. The skeletal muscle clock gene regulates sleep homeostasis, and knockout BMAL1 mice exhibit an attenuated rhythm of sleep-wake distribution during 24 hours.74
Circadian clock genes regulate skeletal muscle rhythms.60,61 More than 2300 circadian clock genes are expressed in human skeletal muscle, and these genes regulate the expression of downstream clock-control genes (CCGs) through transcriptional, translational, and epigenetic means, thereby effectively regulating the rhythmicity of organisms at physiological, metabolic, and behavioral levels.75 Among them, skeletal muscle-specific CCGs include myogenic differentiation 1 (Myod1),76 Atrogin-1,77 dynamin-related protein 1 (Drp1),78 Bcl-2 nineteen-kilodalton interacting protein 3 (BNIP3),79 and so on. These tissue-specific genes not only maintain skeletal muscle mass and prevent muscle atrophy by regulating muscular dystrophy factor, but also interact with the central clock to influence sleep behavior.80 For example, Myod1 is a key upstream factor involved in myogenic differentiation and also regulates the expression of core clock genes.80,81 Despite certain results, the complex mechanisms by which skeletal muscle circadian rhythms affect sleep behavior need to be supported by more researches.
Our study used bidirectional two-sample MR to explore causality and reverse causality between multiple sleep traits and low grip strength based on large sample size databases. Both directions yielded significant results, albeit with some weak effect sizes, suggesting some degree of potential interaction between sleep and grip strength. This may give a universal positive signal that increasing muscle mass to increase grip strength, or consciously improving sleep habits, can consequently improve quality of life and health in old populations.
Several limitations should be considered in our study. Firstly, although we drew on the largest available GWAS data, some traits found insufficient genome-wide significant SNPs. Therefore, we used relaxed P-value thresholds for some analyses, which may result in weak instruments bias.82 Although the F-statistics results assured the efficacy of the genetic instruments, some bias (eg, false positives) may still exist with the relaxed thresholds.40 Secondly, despite selecting strongly associated SNPs, common SNPs do not yet explain much total variance in complex traits and so cannot be considered exact proxies of the exposure. Thirdly, there was some difference in age between the populations for exposure and outcome. The samples in the exposure data from the UK Biobank ranged in age from 40 to 69 years, and the median age of samples from the FinnGen database was 63 years. For outcome, SNPs associated with low grip strength were identified in the CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology) Study of individuals aged 60 to 90. Therefore, we could not avoid bias from age differences. Due to the low hand grip strength being an important symptom of frailty, the GWAS data on low hand grip strength are restricted to an older population, which might limit the generalizability of the findings to younger populations. However, age differences in two-sample MR studies generally do not increase the likelihood of incorrectly inferring a causal association.83 Moreover, datasets restricted to European ancestry limited the bias due to population stratification and clinical generalizability to other populations. However, despite some limitations, our findings are novel and provide data support and a theoretical basis for clinical improvement of quality of life in older adults.
Conclusion
This study leverages MR to explore causal associations regarding sleep traits and low grip strength risk. Our findings validate a potential causal association between sleep-related phenotypes and low grip strength risk, including sleep duration, sleep-wake disorders, and daytime napping. Furthermore, we speculate on possible physiological mechanisms from the skeletal muscle circadian rhythms perspective. Effective interventions are of great necessity to improve the elderly sleep and muscle function from an early stage. These findings have implications for establishing feasible disease screening and prevention strategies.
Data Sharing Statement
The data presented in this study are available on reasonable request from the corresponding author. Original data on sleep traits and low grip strength were obtained from the IEU GWAS database (https://gwas.mrcieu.ac.uk/), Finngen database (https://www.finngen.fi/en), and original GWAS studies.
Ethics Approval
The ethics committee of Beijing Sport University strictly adheres to the Declaration of Helsinki and the International Ethical Guidelines for Health-related Research Involving Humans. The present study uses legally obtained publicly available data, meeting the conditions for exemption from review as stated in the Measures for Ethical Review Methods for Life Sciences and Medical Research Involving Humans.
Acknowledgments
We want to acknowledge the participants and investigators of the FinnGen study, UK Biobank, MRC-IEU and other original GWAS studies.
Author contributions
All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.
Funding
This research was funded by the Fundamental Research Business Expenses of the Central Universities (Grant No. 2024GCZX002, 2024GCZX005, PD-GCZX002, PD-GCZX006, and 2022YB019); the Open Project of State Key Laboratory of Basic and Applied Aerospace Medicine (Grant No. SMFA20K04).
Disclosure
The authors report no conflicts of interest in this work.
References
1. Vaishya R, Misra A, Vaish A, Ursino N, D’Ambrosi R. Hand grip strength as a proposed new vital sign of health: a narrative review of evidences. J Health Popul Nutr. 2024;43(1):7. doi:10.1186/s41043-024-00500-y
2. Wu Y, Wang W, Liu T, Zhang D. Association of grip strength with risk of all-cause mortality, cardiovascular diseases, and cancer in community-dwelling populations: a meta-analysis of prospective cohort studies. J Am Med Dir Assoc. 2017;18(6):551e517–551e535. doi:10.1016/j.jamda.2017.03.011
3. Hamasaki H, Kawashima Y, Katsuyama H, Sako A, Goto A, Yanai H. Association of handgrip strength with hospitalization, cardiovascular events, and mortality in Japanese patients with type 2 diabetes. Sci Rep. 2017;7(1). doi:10.1038/s41598-017-07438-8
4. Lin MH, Chang CY, Wu DM, Lu CH, Kuo CC, Chu NF. Relationship of multimorbidity, obesity status, and grip strength among older adults in Taiwan. Int J Environ Res Public Health. 2021;18(14):7540.
5. Burtin C, Ter Riet G, Puhan MA, et al. Handgrip weakness and mortality risk in COPD: a multicentre analysis. Thorax. 2016;71(1):86–87. doi:10.1136/thoraxjnl-2015-207451
6. Cooper R, Kuh D, Hardy R, Mortality Review G; Falcon, Teams HAS. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ. 2010:341:c4467.
7. Wang Y, Meng T, Yang W, et al. Association of grip strength and comorbidities with all-cause mortality in the older hypertensive adults. Front Public Health. 2023;11:1162425. doi:10.3389/fpubh.2023.1162425
8. Lopez-Bueno R, Andersen LL, Calatayud J, et al. Associations of handgrip strength with all-cause and cancer mortality in older adults: a prospective cohort study in 28 countries. Age Ageing. 2022;51(5). doi:10.1093/ageing/afac117.
9. Liu J, Zhang T, Luo J, Chen S, Zhang D. Association between sleep duration and grip strength in U.S. older adults: an NHANES analysis (2011-2014). Int J Environ Res Public Health. 2023;20(4):3416.
10. Buchmann N, Spira D, Norman K, Demuth I, Eckardt R, Steinhagen-Thiessen E. Sleep, muscle mass and muscle function in older people. Dtsch Arztebl Int. 2016;113(15):253–260. doi:10.3238/arztebl.2016.0253
11. Han Q, Hu W, Sun N, et al. Bidirectional associations between sleep quality and grip strength and the mediating role of depression: evidence from two nationally representative cohorts. J Gerontol a Biol Sci Med Sci. 2023;78(12):2449–2457. doi:10.1093/gerona/glad084
12. Everson CA, Crowley WR. Reductions in circulating anabolic hormones induced by sustained sleep deprivation in rats. Am J Physiol Endocrinol Metab. 2004;286(6):E1060–1070. doi:10.1152/ajpendo.00553.2003
13. Van Cauter E, Spiegel K, Tasali E, Leproult R. Metabolic consequences of sleep and sleep loss. Sleep Med. 2008;9(Suppl 1(0 1)):S23–28. doi:10.1016/S1389-9457(08)70013-3
14. Sun XH, Ma T, Yao S, et al. Associations of sleep quality and sleep duration with frailty and pre-frailty in an elderly population Rugao longevity and ageing study. BMC Geriatr. 2020;20(1):9. doi:10.1186/s12877-019-1407-5
15. Cheng P, Drake CL. Psychological impact of shift work. Curr Sleep Med Rep. 2018;4(2):104–109. doi:10.1007/s40675-018-0114-7
16. Choi YI, Park DK, Chung JW, Kim KO, Kwon KA, Kim YJ. Circadian rhythm disruption is associated with an increased risk of sarcopenia: a nationwide population-based study in Korea. Sci Rep. 2019;9(1):12015. doi:10.1038/s41598-019-48161-w
17. Yu DS, Lee DT, Man NW. Fatigue among older people: a review of the research literature. Int J Nurs Stud. 2010;47(2):216–228. doi:10.1016/j.ijnurstu.2009.05.009
18. Gulia KK, Kumar VM. Sleep disorders in the elderly: a growing challenge. Psychogeriatrics. 2018;18(3):155–165. doi:10.1111/psyg.12319
19. Sanderson E, Glymour MM, Holmes MV, et al. Mendelian randomization. Nat Rev Meth Primers. 2022;2:6.
20. Riaz H, Khan MS, Siddiqi TJ, et al. Association between obesity and cardiovascular outcomes: a systematic review and meta-analysis of Mendelian randomization studies. JAMA Network Open. 2018;1(7):e183788. doi:10.1001/jamanetworkopen.2018.3788
21. Zheng J, Baird D, Borges MC, et al. Recent developments in Mendelian randomization studies. Curr Epidemiol Rep. 2017;4(4):330–345. doi:10.1007/s40471-017-0128-6
22. Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021;375:n2233. doi:10.1136/bmj.n2233
23. Elsworth B Sleep duration: dataset: ukb–b–4424. 2018; Available from: https://gwas.mrcieu.ac.uk/datasets/ukb-b-4424/.
24. Dashti HS, Jones SE, Wood AR, et al. Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates. Nat Commun. 2019;10(1):1100. doi:10.1038/s41467-019-08917-4
25. Kurki MI, Karjalainen J, Palta P, et al. FinnGen: unique genetic insights from combining isolated population and national health register data. medRxiv. 2022:22271360. doi:10.1101/2022.03.03.22271360.
26. Dashti HS, Daghlas I, Lane JM, et al. Genetic determinants of daytime napping and effects on cardiometabolic health. Nat Commun. 2021;12(1):900. doi:10.1038/s41467-020-20585-3
27. Jones SE, Lane JM, Wood AR, et al. Genome-wide association analyses of chronotype in 697,828 individuals provides insights into circadian rhythms. Nat Commun. 2019;10(1):343. doi:10.1038/s41467-018-08259-7
28. Jones G, Trajanoska K, Santanasto AJ, et al. Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women. Nat Commun. 2021;12(1):654. doi:10.1038/s41467-021-20918-w
29. Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11):e1007081. doi:10.1371/journal.pgen.1007081
30. Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755–764. doi:10.1093/ije/dyr036
31. Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG, Consortium E-I. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30(7):543–552. doi:10.1007/s10654-015-0011-z
32. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–314. doi:10.1002/gepi.21965
33. Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961–1974. doi:10.1093/ije/dyw220
34. Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–698. doi:10.1038/s41588-018-0099-7
35. Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195–R208. doi:10.1093/hmg/ddy163
36. Mounier N, Kutalik Z. Bias correction for inverse variance weighting Mendelian randomization. Genet Epidemiol. 2023;47(4):314–331. doi:10.1002/gepi.22522
37. Walker VM, Davies NM, Hemani G, et al. Using the MR-base platform to investigate risk factors and drug targets for thousands of phenotypes. Wellcome Open Res. 2019;4:113. doi:10.12688/wellcomeopenres.15334.1
38. Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample Mendelian randomization. Genet Epidemiol. 2016;40(7):597–608. doi:10.1002/gepi.21998
39. Palmer TM, Lawlor DA, Harbord RM, et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012;21(3):223–242. doi:10.1177/0962280210394459
40. Chen Z, Boehnke M, Wen X, Mukherjee B. Revisiting the genome-wide significance threshold for common variant GWAS. G3. 2021;11(2). doi:10.1093/g3journal/jkaa056
41. Suetta C, Haddock B, Alcazar J, et al. The Copenhagen Sarcopenia Study: lean mass, strength, power, and physical function in a Danish cohort aged 20–93 years. J Cachexia, Sarcopenia and Muscle. 2019;10(6):1316–1329. doi:10.1002/jcsm.12477
42. Porto JM, Nakaishi APM, Cangussu-Oliveira LM, Freire Júnior RC, Spilla SB, DCCd A. Relationship between grip strength and global muscle strength in community-dwelling older people. Arch Gerontol Geriatrics. 2019;82:273–278. doi:10.1016/j.archger.2019.03.005
43. Wang Z, Zeng Z. Association between personality characteristics and sleep quality among Chinese middle-aged and older adults: evidence from China family panel studies. BMC Public Health. 2023;23(1):2427. doi:10.1186/s12889-023-17352-6
44. Spira AP, Kaufmann CN, Stone KL. Sleep, circadian rhythms, and aging: advancing knowledge to promote older adults’ health. J Gerontol a Biol Sci Med Sci. 2023;78(10):1812–1815. doi:10.1093/gerona/glad195
45. Xu Q, Ou X, Li J. The risk of falls among the aging population: a systematic review and meta-analysis. Front Public Health. 2022;10:902599. doi:10.3389/fpubh.2022.902599
46. Hsu NW, Lin CH, Yang NP, Chen HC, Chou P. Handgrip strength is associated with mortality in community-dwelling older adults: the Yilan cohort study, Taiwan. BMC Public Health. 2023;23(1):2194. doi:10.1186/s12889-023-17058-9
47. Fabrega-Cuadros R, Cruz-Diaz D, Martinez-Amat A, Aibar-Almazan A, Redecillas-Peiro MT, Hita-Contreras F. Associations of sleep and depression with obesity and sarcopenia in middle-aged and older adults. Maturitas. 2020;142:1–7. doi:10.1016/j.maturitas.2020.06.019
48. Pana A, Sourtzi P, Kalokairinou A, Pastroudis A, Chatzopoulos ST, Velonaki VS. Association between muscle strength and sleep quality and duration among middle-aged and older adults: a systematic review. Eur Geriatr Med. 2021;12(1):27–44. doi:10.1007/s41999-020-00399-8
49. Wen QR, Wu M, Pan L, et al. The correlation of sleep duration and insomnia with low muscle mass, strength and quality in Chinese adults. Zhonghua Liu Xing Bing Xue Za Zhi. 2022;43(2):175–182. doi:10.3760/cma.j.cn112338-20201020-01252
50. Chen HC, Hsu NW, Chou P. The association between sleep duration and hand grip strength in community-dwelling older adults: the Yilan study, Taiwan. Sleep. 2017;40(4). doi:10.1093/sleep/zsx021
51. Matsumoto T, Tanizawa K, Tachikawa R, et al. Associations of obstructive sleep apnea with truncal skeletal muscle mass and density. Sci Rep. 2018;8(1):6550. doi:10.1038/s41598-018-24750-z
52. Lucassen EA, de Mutsert R, le Cessie S, et al. Poor sleep quality and later sleep timing are risk factors for osteopenia and sarcopenia in middle-aged men and women: the NEO study. PLoS One. 2017;12(5):e0176685. doi:10.1371/journal.pone.0176685
53. Lamon S, Morabito A, Arentson-Lantz E, et al. The effect of acute sleep deprivation on skeletal muscle protein synthesis and the hormonal environment. Physiol Rep. 2021;9(1):e14660. doi:10.14814/phy2.14660
54. Dattilo M, Antunes HK, Medeiros A, et al. Sleep and muscle recovery: endocrinological and molecular basis for a new and promising hypothesis. Med Hypotheses. 2011;77(2):220–222. doi:10.1016/j.mehy.2011.04.017
55. Chennaoui M, Leger D, Gomez-Merino D. Sleep and the GH/IGF-1 axis: consequences and countermeasures of sleep loss/disorders. Sleep Med Rev. 2020;49:101223. doi:10.1016/j.smrv.2019.101223
56. Hulett NA, Scalzo RL, Reusch JEB. Glucose uptake by skeletal muscle within the contexts of Type 2 diabetes and exercise: an integrated approach. Nutrients. 2022;14(3):647. doi:10.3390/nu14030647
57. Merz KE, Thurmond DC. Role of skeletal muscle in insulin resistance and glucose uptake. Compr Physiol. 2020;10(3):785–809.
58. Syauqy A, Hsu CY, Rau HH, Kurniawan AL, Chao JC. Association of sleep duration and insomnia symptoms with components of metabolic syndrome and inflammation in middle-aged and older adults with metabolic syndrome in Taiwan. Nutrients. 2019;11(8):1848. doi:10.3390/nu11081848
59. Abbatecola AM, Paolisso G, Fattoretti P, et al. Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction. J Nutr Health Aging. 2011;15(10):890–895. doi:10.1007/s12603-011-0366-0
60. Chatterjee S, Ma K. Circadian clock regulation of skeletal muscle growth and repair. F1000Res. 2016;5:1549. doi:10.12688/f1000research.9076.1
61. Harfmann BD, Schroder EA, Esser KA. Circadian rhythms, the molecular clock, and skeletal muscle. J Biol Rhythms. 2015;30(2):84–94. doi:10.1177/0748730414561638
62. Zhang H, Liang J, Chen N. Do not neglect the role of circadian rhythm in muscle atrophy. Ageing Res Rev. 2020;63:101155. doi:10.1016/j.arr.2020.101155
63. Botonis PG, Koutouvakis N, Toubekis AG. The impact of daytime napping on athletic performance - A narrative review. Scand J Med Sci Sports. 2021;31(12):2164–2177. doi:10.1111/sms.14060
64. Goldman SE, Stone KL, Ancoli-Israel S, et al. Poor sleep is associated with poorer physical performance and greater functional limitations in older women. Sleep. 2007;30(10):1317–1324. doi:10.1093/sleep/30.10.1317
65. Zhang Y, Zhou L, Ge M, Lin X, Dong B. Association between daytime nap duration and risks of frailty: findings from the China health and retirement longitudinal study. Front Public Health. 2022;10:1098609. doi:10.3389/fpubh.2022.1098609
66. Deng Z, Hu Y, Duan L, et al. Causality between sleep traits and the risk of frailty: a Mendelian randomization study. Front Public Health. 2024;12:1381482. doi:10.3389/fpubh.2024.1381482
67. McGrath RP, Kraemer WJ, Snih SA, Peterson MD. Handgrip strength and health in aging adults. Sports Med. 2018;48(9):1993–2000. doi:10.1007/s40279-018-0952-y
68. Yamada T, Hara K, Shojima N, Yamauchi T, Kadowaki T. Daytime napping and the risk of cardiovascular disease and all-cause mortality: a prospective study and dose-response meta-analysis. Sleep. 2015;38(12):1945–1953. doi:10.5665/sleep.5246
69. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5-TR), fifth edition. Text Rivision. 2022.
70. Morrison M, Halson SL, Weakley J, Hawley JA. Sleep, circadian biology and skeletal muscle interactions: implications for metabolic health. Sleep Med Rev. 2022;66:101700. doi:10.1016/j.smrv.2022.101700
71. Youngstedt SD, Elliott JA, Kripke DF. Human circadian phase-response curves for exercise. J Physiol. 2019;597(8):2253–2268. doi:10.1113/JP276943
72. Seol J, Lee J, Nagata K, et al. Combined effect of daily physical activity and social relationships on sleep disorder among older adults: cross-sectional and longitudinal study based on data from the Kasama study. BMC Geriatr. 2021;21(1):623. doi:10.1186/s12877-021-02589-w
73. Nishikawa H, Asai A, Fukunishi S, Nishiguchi S, Higuchi K. Metabolic syndrome and sarcopenia. Nutrients. 2021;13(10):3519. doi:10.3390/nu13103519
74. Laposky A, Easton A, Dugovic C, Walisser J, Bradfield C, Turek F. Deletion of the mammalian circadian clock gene BMAL1/Mop3 alters baseline sleep architecture and the response to sleep deprivation. Sleep. 2005;28(4):395–409. doi:10.1093/sleep/28.4.395
75. Choi Y, Cho J, No MH, et al. Re-setting the circadian clock using exercise against sarcopenia. Int J Mol Sci. 2020;21(9):3106.
76. Zhang X, Patel SP, McCarthy JJ, Rabchevsky AG, Goldhamer DJ, Esser KA. A non-canonical E-box within the MyoD core enhancer is necessary for circadian expression in skeletal muscle. Nucleic Acids Res. 2012;40(8):3419–3430. doi:10.1093/nar/gkr1297
77. Hodge BA, Wen Y, Riley LA, et al. The endogenous molecular clock orchestrates the temporal separation of substrate metabolism in skeletal muscle. Skelet Muscle. 2015;5(1):17. doi:10.1186/s13395-015-0039-5
78. Schmitt K, Grimm A, Dallmann R, et al. Circadian control of DRP1 activity regulates mitochondrial dynamics and bioenergetics. Cell Metab. 2018;27(3):657–666e655. doi:10.1016/j.cmet.2018.01.011
79. Li E, Li X, Huang J, et al. BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy. Protein Cell. 2020;11(9):661–679. doi:10.1007/s13238-020-00713-x
80. Mayeuf-Louchart A, Staels B, Duez H. Skeletal muscle functions around the clock. Diabetes Obes Metab. 2015;17(Suppl 1):39–46. doi:10.1111/dom.12517
81. Hodge BA, Zhang X, Gutierrez-Monreal MA, et al. MYOD1 functions as a clock amplifier as well as a critical co-factor for downstream circadian gene expression in muscle. Elife. 2019;8: e43017.
82. Wray NR, Yang J, Hayes BJ, Price AL, Goddard ME, Visscher PM. Pitfalls of predicting complex traits from SNPs. Nat Rev Genet. 2013;14(7):507–515. doi:10.1038/nrg3457
83. Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7. doi:10.7554/eLife.34408
© 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.